Neurocrine Biosciences (NBIX) Tops Q3 EPS by 12c

Neurocrine Biosciences (NASDAQ: NBIX) reported Q3 EPS of ($0.45), $0.12 better than the analyst estimate of ($0.57).

For earnings history and earnings-related data on Neurocrine Biosciences (NBIX) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• Benchmark Reiterates Buy Rating on Odysight.AI Inc. (ODYS)
• L3Harris CEO steps down amid conduct review, shares drop